DE60027890D1 - Streptococcus pneumoniae proteine und impfstoffe - Google Patents

Streptococcus pneumoniae proteine und impfstoffe

Info

Publication number
DE60027890D1
DE60027890D1 DE60027890T DE60027890T DE60027890D1 DE 60027890 D1 DE60027890 D1 DE 60027890D1 DE 60027890 T DE60027890 T DE 60027890T DE 60027890 T DE60027890 T DE 60027890T DE 60027890 D1 DE60027890 D1 DE 60027890D1
Authority
DE
Germany
Prior art keywords
vaccines
streptococcus pneumoniae
pneumoniae proteins
polypeptides
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027890T
Other languages
English (en)
Other versions
DE60027890T2 (de
Inventor
E Adamou
H Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
MedImmune LLC
Original Assignee
Human Genome Sciences Inc
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, MedImmune LLC filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of DE60027890D1 publication Critical patent/DE60027890D1/de
Publication of DE60027890T2 publication Critical patent/DE60027890T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
DE60027890T 1999-06-10 2000-06-09 Streptococcus pneumoniae proteine und impfstoffe Expired - Lifetime DE60027890T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13845399P 1999-06-10 1999-06-10
US138453P 1999-06-10
PCT/US2000/015925 WO2000076540A2 (en) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteins and vaccines

Publications (2)

Publication Number Publication Date
DE60027890D1 true DE60027890D1 (de) 2006-06-14
DE60027890T2 DE60027890T2 (de) 2007-04-19

Family

ID=22482080

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60045721T Expired - Lifetime DE60045721D1 (de) 1999-06-10 2000-06-09 Streptococcus pneumoniae Proteine und Impfstoffe
DE60027890T Expired - Lifetime DE60027890T2 (de) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteine und impfstoffe

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60045721T Expired - Lifetime DE60045721D1 (de) 1999-06-10 2000-06-09 Streptococcus pneumoniae Proteine und Impfstoffe

Country Status (9)

Country Link
EP (2) EP1185297B1 (de)
JP (1) JP2003501110A (de)
AT (2) ATE325620T1 (de)
AU (1) AU777856B2 (de)
CA (1) CA2371714C (de)
DE (2) DE60045721D1 (de)
ES (2) ES2360296T3 (de)
HK (1) HK1043943A1 (de)
WO (1) WO2000076540A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081530B1 (en) 1997-07-02 2006-07-25 sanofi pasteur limitée Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
AU2002351623A1 (en) 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
NZ569076A (en) 2005-12-22 2011-08-26 Glaxosmithkline Biolog Sa Vaccine comprising capsular polysaccharides conjugates from Streptococcus pneumoniae serotypes 19A and 19F
DK2167121T3 (en) 2007-06-26 2015-11-23 Glaxosmithkline Biolog Sa A vaccine comprising Streptococcus pneumoniae kapselpolysaccharidkonjugater
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US20110020403A1 (en) 2007-12-13 2011-01-27 Bengt Guss immunizing composition
PT2268618E (pt) 2008-03-03 2015-10-12 Novartis Ag Compostos e composições moduladores da actividade tlr
CA2720961A1 (en) 2008-04-16 2009-10-22 William Ripley Ballou, Jr. Streptococcus pneumonia vaccine
AU2010258677B2 (en) 2009-06-10 2016-10-06 Glaxosmithkline Biologicals S.A. Benzonaphthyridine-containing vaccines
WO2011008548A1 (en) 2009-06-29 2011-01-20 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
JP5988492B2 (ja) 2009-09-02 2016-09-07 ノバルティス アーゲー Ｔｌｒ活性モジュレーターを含む免疫原性組成物
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
KR20120081587A (ko) 2009-09-10 2012-07-19 노파르티스 아게 기도 질병에 대한 조합 백신
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
WO2011084549A1 (en) 2009-12-15 2011-07-14 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
WO2011119759A1 (en) 2010-03-23 2011-09-29 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
AU2012207088A1 (en) 2011-01-20 2013-05-02 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae
BR112013029514A2 (pt) 2011-05-17 2019-09-24 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, e, método de tratar ou impedir uma doença
US20150132339A1 (en) 2012-03-07 2015-05-14 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
BR112015018014A2 (pt) 2013-02-01 2017-07-11 Glaxosmithkline Biologicals Sa liberação intradérmica de composições imunológicas compreendendo agonistas do receptor do tipo toll
CA3090271A1 (en) 2018-02-12 2019-08-15 Inimmune Corporation Toll-like receptor ligands
KR20230117105A (ko) 2020-11-04 2023-08-07 엘리고 바이오사이언스 큐티박테리움 아크네스 재조합 파지, 그의 제조 방법 및 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1400592A1 (de) * 1996-10-31 2004-03-24 Human Genome Sciences, Inc. Polynukleotide und Sequenzen aus Streptococcus Pneumoniae
CN1318103A (zh) * 1998-07-27 2001-10-17 微生物技术有限公司 肺炎链球菌的核酸和蛋白质

Also Published As

Publication number Publication date
CA2371714C (en) 2012-12-04
WO2000076540A3 (en) 2001-02-08
EP1731166B1 (de) 2011-03-09
DE60027890T2 (de) 2007-04-19
WO2000076540A2 (en) 2000-12-21
DE60045721D1 (de) 2011-04-21
ATE500843T1 (de) 2011-03-15
EP1185297A2 (de) 2002-03-13
CA2371714A1 (en) 2000-12-21
AU777856B2 (en) 2004-11-04
EP1185297B1 (de) 2006-05-10
ES2264419T3 (es) 2007-01-01
ATE325620T1 (de) 2006-06-15
ES2360296T3 (es) 2011-06-02
EP1731166A2 (de) 2006-12-13
JP2003501110A (ja) 2003-01-14
HK1043943A1 (zh) 2002-10-04
EP1731166A3 (de) 2007-02-21
AU5477800A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
ATE500843T1 (de) Streptococcus pneumoniae proteine und impfstoffe
NZ512574A (en) Novel streptococcus antigens useful as vaccines
WO2001098334A3 (en) Streptococcus antigens
ATE422899T1 (de) Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
ATE276758T1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
MY125202A (en) Vaccine
DE60036698D1 (de) Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
AU9063801A (en) Methods and compositions for diseases associated with amyloidosis
DK0778781T3 (da) Pneumokok-polysaccharid-rekombinant pneumolysin-konjugat-vacciner til immunisering mod pneumokokinfektioner
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
NO980883L (no) Forbindelser og fremgangsmÕter for immunterapi og diagnose av tuberkulose
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2002072036A3 (en) Compositions and methods comprising west nile virus polypeptides
WO1999042588A3 (en) Group b streptococcus antigens
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
NO20015074D0 (no) Nye sammensetninger
WO2002045742A8 (en) Lipoteichoic acid immunogenic compositions and methods of making and using thereof
WO2000058475A3 (en) Streptococcus pneumoniae antigens
EA200100700A1 (ru) Гены и белки и их применение
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
EP1090995A3 (de) Mycoplasma hyopneumoniae Antigen MHP3, dafür kodierendes Gen und Ihre Verwendungen
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente

Legal Events

Date Code Title Description
8364 No opposition during term of opposition